The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
GOG0076-GG: A limited access phase II trial of pemetrexed (LY231514) (NSC #698037) in combination with cisplatin (NSC #119875) in the treatment of advanced, persistent, or recurrent carcinoma of the cervix—A Gynecologic Oncology Group study.
David S. Miller
No relevant relationships to disclose
John A. Blessing
No relevant relationships to disclose
Lois M. Ramondetta
No relevant relationships to disclose
Huyen Pham
No relevant relationships to disclose
Krishnansu Sujata Tewari
No relevant relationships to disclose
Lisa Michelle Landrum
No relevant relationships to disclose
Jubilee Brown
No relevant relationships to disclose
Robert S. Mannel
No relevant relationships to disclose